Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

May 28, 2020

Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Nutrition
    /
Abstract The precise etiology of multiple sclerosis (MS) is unknown but epidemiologic evidence suggests this immune-mediated, neurodegenerative condition is the…
MS Research Study and Reports

May 28, 2020

Siponimod Reduces Risk of Disability Progression Regardless of Prior Relapses in MS

  • MS Drug Therapies
    /
  • MS Relapse-Exacerbation
    /
Data from the phase 3 EXPAND clinical trial (NCT01665144) of siponimod (Mayzent; Novartis) demonstrated the treatment’s ability to reduce the…
MS Drug Therapies

May 28, 2020

THIS DIET MAY EASE FATIGUE FOR PEOPLE WITH MS

  • Multiple Sclerosis
    /
  • Nutrition
    /
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ COVID-19 is unprecedented and rapidly changing situation. Get public health information from CDC: https://www.coronavirus.gov  Stay Healthy, Stay Home and Wash…
Multiple Sclerosis

May 28, 2020

TRANSPLANTED BRAIN CELLS REPAIR MS DAMAGE IN MICE

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
MAY 20TH, 2020  –POSTED BY MARK MICHAUD-ROCHESTER Click HERE to Subscribe for the MS Beacon Newsletter When researchers transplanted specific…
MS Research Study and Reports

May 28, 2020

BACK Novartis builds case for MS drug ofatumumab as FDA decision looms

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Click HERE to Subscribe for the MS Beacon Newsletter May 27, 2020 Novartis has reported new data with its multiple…
MS Drug Therapies

May 27, 2020

Consortium of Multiple Sclerosis Centers Annual Meeting 2020, event updates

  • MS Educational Programs
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis Videos
    /
  • Virtual MS event
    /
Click HERE to Subscribe for the MS Beacon Newsletter The annual meeting of the Consortium of Multiple Sclerosis Centers (#CMSC)…
MS Educational Programs

May 27, 2020

Natalizumab (Tysabri) Provides Superior ‘Feel Good’ Experience in MS Over Other Treatments

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ COVID-19 is unprecedented and rapidly changing situation. Get public health information from CDC: https://www.coronavirus.gov  Stay Healthy, Stay Home and Wash…
MS Research Study and Reports

May 27, 2020

A Tattoo Therapy with Nanoparticles, may help treat Multiple Sclerosis : STUDY

  • MS Research Study and Reports
    /
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov  Stay Healthy, Stay Home…
MS Research Study and Reports

May 27, 2020

Ofatumumab Increases NEDA-3 ( no evidence of disease activity) Likelihood in MS, Compared With Teriflunomide

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Novartis’s anti-CD20 monoclonal antibody has been shown to increase the odds of patients with multiple sclerosis achieving no evidence of…
MS Drug Therapies

May 27, 2020

Amid the COVID-19 Pandemic, Neurologists in Canada Report Pulling Back from EMD Serono’s Mavenclad and Sanofi Genzyme’s Lemtrada, While Roche’s Ocrevus Stalls, According to Spherix Global Insights

  • #COVID-19
    /
  • MS Drug Therapies
    /
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov  Stay Healthy, Stay Home…
#COVID-19

Categories

Latest Blog Posts